ijps 2020
DOI: 10.36468/pharmaceutical-sciences.spl.136
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Dysglycemia and Dyslipidemia on the Severity of Airflow Limitation in Patients with Chronic Obstructive Pulmonary Disease

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles